Shandong Sanyuan Biotechnology Co.Ltd. Market Cap ($639.50 Million)
Market Cap & Net Worth: Shandong Sanyuan Biotechnology Co.Ltd. (301206)
Shandong Sanyuan Biotechnology Co.Ltd. market cap. Shandong Sanyuan Biotechnology Co.Ltd. (SHE:301206) has a market capitalization of $639.50 Million (CN¥4.37 Billion) as of November 1, 2026. Listed on the SHE stock exchange, this China-based company holds position #10627 globally and #2791 in its home market, demonstrating a -7.89% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shandong Sanyuan Biotechnology Co.Ltd.'s stock price CN¥21.60 by its total outstanding shares 202325700 (202.33 Million). Also see 301206 cash flow conversion for how efficiently the company converts equity into cash flow.
Shandong Sanyuan Biotechnology Co.Ltd. Market Cap History (2022–2026)
Shandong Sanyuan Biotechnology Co.Ltd. market cap history from 2022 to 2026. Data shows change from $1.11 Billion to $639.50 Million (-24.30% CAGR). Check Shandong Sanyuan Biotechnology Co.Ltd. share price for real-time trading data and today's change.
Shandong Sanyuan Biotechnology Co.Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shandong Sanyuan Biotechnology Co.Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 301206 net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.09x
Shandong Sanyuan Biotechnology Co.Ltd.'s market cap is 1.09 times its annual revenue
Latest Price to Earnings (P/E) Ratio
7.39x
Shandong Sanyuan Biotechnology Co.Ltd.'s market cap is 7.39 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $1.11 Billion | $674.91 Million | $163.69 Million | 1.65x | 6.79x |
| 2023 | $842.33 Million | $499.50 Million | $58.87 Million | 1.69x | 14.31x |
| 2024 | $775.99 Million | $712.90 Million | $104.95 Million | 1.09x | 7.39x |
Competitor Companies of 301206 by Market Capitalization
Companies near Shandong Sanyuan Biotechnology Co.Ltd. in the global market cap rankings as of November 1, 2026. Also see 301206 current and non-current assets for a full breakdown of the balance sheet.
Key companies related to Shandong Sanyuan Biotechnology Co.Ltd. by market ranking:
- Mondelez International Inc (NASDAQ:MDLZ): Ranked #344 globally with a market cap of $79.67 Billion USD.
- Hershey Co (NYSE:HSY): Ranked #1063 globally with a market cap of $24.55 Billion USD.
- Chocoladefabriken Lindt & Spruengli AG N (SW:LISN): Ranked #1619 globally with a market cap of $14.59 Billion USD ( CHF11.54 Billion CHF).
- Chocoladefabriken Lindt & Spruengli AG Part (SW:LISP): Ranked #2114 globally with a market cap of $10.33 Billion USD ( CHF8.17 Billion CHF).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #344 | Mondelez International Inc | NASDAQ:MDLZ | $79.67 Billion | $64.94 |
| #1063 | Hershey Co | NYSE:HSY | $24.55 Billion | $165.61 |
| #1619 | Chocoladefabriken Lindt & Spruengli AG N | SW:LISN | $14.59 Billion | CHF86200.00 |
| #2114 | Chocoladefabriken Lindt & Spruengli AG Part | SW:LISP | $10.33 Billion | CHF8420.00 |
Market Capitalization of Shandong Sanyuan Biotechnology Co.Ltd. (2022–2026)
Market capitalization of Shandong Sanyuan Biotechnology Co.Ltd. from 2022 to today. Between 2022 and today, Shandong Sanyuan Biotechnology Co.Ltd.'s market cap moved from $1.11 Billion to $ 639.50 Million, with a yearly change of -24.30%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥639.50 Million | -17.84% |
| 2025 | CN¥778.36 Million | +0.31% |
| 2024 | CN¥775.99 Million | -7.88% |
| 2023 | CN¥842.33 Million | -24.22% |
| 2022 | CN¥1.11 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 1st, 2026 the market cap of Shandong Sanyuan Biotechnology Co.Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $639.50 Million USD |
| MoneyControl | $639.50 Million USD |
| MarketWatch | $639.50 Million USD |
| marketcap.company | $639.50 Million USD |
| Reuters | $639.50 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shandong Sanyuan Biotechnology Co.Ltd.
Shandong Sanyuan Biotechnology Co.,Ltd. engages in the research and development, production, and sale of erythritol and compound sugar products in China. Its products are used in table sugar, flavored sugar, and beverages; candy and chocolate food; baked food; health food; medical supplies; cosmetic products; chemical products; and other applications. The company exports its products to Europe, t… Read more